Ligand Pharmaceuticals Statistics
NASDAQ: LGNDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
295.00+1.74 (+0.59%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ligand Pharmaceuticals by the numbers
Ligand Pharmaceuticals has a market capitalization of $5.88 billion based on 19.94M shares outstanding. Its trailing P/E ratio is 31.1, and its forward P/E is 24.7. The stock trades 1.1% above its 50-day average and 21.2% above its 200-day average.
Average daily trading volume is 262.72K shares, or about $77.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
LGND valuation vs. peer median
| Metric | LGND | Peer median | Difference |
|---|---|---|---|
| Market cap | $5.88B | $5.35B | +10% |
| Forward P/E | 24.7 | 36.0 | -31% |
| Avg. volume | 262.72K | 673.90K | -61% |
Peer median across 8 companies: BLTE, KNSA, RYTM, ERAS, MANE, MIRM, PTCT, GRFS.
Valuation
- Market cap
- $5.88B
- P/E (TTM)
- 31.09
- Forward P/E
- 24.69
- Price / sales (latest FY)
- 21.94
- EPS (TTM)
- $9.49
- Shares outstanding
- 19.94M
Price and trading
- Previous close
- 293.26
- Open
- 290.41
- Day range
- 281.74 – 296.48
- 52-week range
- 175.89 – 326.63
- 52-week change
- +60.11%
- 50-day moving average
- 291.79
- 200-day moving average
- 243.31
- Beta
- —
- Volume
- 318.88K
- Average volume
- 262.72K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 5.88B
- Pe
- 31.09
- Forward Pe
- 24.69
- Eps
- 9.49
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 326.63
- Week52 Low
- 175.89
- Avg Volume
- 262.72K
- Shares Outstanding
- 19.94M
- Ma50
- 291.79
- Ma200
- 243.31
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -9.68%
- Pct From52w Low
- 67.72%